- Home
- SGMT vs BKN Comparison
SGMT vs BKN Comparison
Compare SGMT & BKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | SGMT | BKN |
|---|---|---|
| Founded | 2006 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 204.2M | 197.0M |
| IPO Year | 2023 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMT | BKN |
|---|---|---|
| Price | $5.21 | $11.52 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $27.00 | N/A |
| AVG Volume (30 Days) | ★ 800.4K | 55.5K |
| Earning Date | 03-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.38% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $125.00 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.73 | $9.57 |
| 52 Week High | $11.41 | $12.69 |
Technical Indicators
Market Signals| Indicator | SGMT | BKN |
|---|---|---|
| Relative Strength Index (RSI) | 39.15 | 61.19 |
| Support Level | $5.31 | $11.41 |
| Resistance Level | $5.74 | $11.58 |
| Average True Range (ATR) | 0.52 | 0.10 |
| MACD | -0.06 | 0.01 |
| Stochastic Oscillator | 8.70 | 85.71 |
Price Performance
Historical ComparisonAbout SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About BKN BlackRock Investment Quality Municipal Trust Inc. (The)
Blackrock Investment Quality Municipal Trust, Inc. is a closed-end management investment fund with the investment objective to provide high current income exempt from regular U.S. federal income tax consistent with the preservation of capital.